Stories about MET
- Language:
-
Media:
All
- Period:
- Period:Total
- more
Data From Merck at ASCO 2020 to Showcase Significant Clinical Advances in Cancer Care
moreMerck Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations
moreNew Data at ESMO 2019 for Merck Highlight Focused Clinical Development and Commitment to Patient Care
moreMerck Announces FDA Breakthrough Therapy Designation for Investigational Therapy Tepotinib in Patients with Metastatic NSCLC with METex14 Skipping Alterations
moreUpdated Results for Investigational Therapy Tepotinib Presented at WCLC 2019
moreMerck Presents Updated Results for Investigational Therapy Tepotinib Demonstrating Durable Clinical Response in Patients with Advanced NSCLC with METex14 Skipping Mutations
more
1